The paths of these two stars have intersected on several occasions due to their association with the luxury brand Bulgari
entertainment6 hours ago
Novavax Inc’s Covid-19 vaccine was 96 per cent effective in preventing cases caused by the original version of the coronavirus in a late-stage trial conducted in the United Kingdom, the company said on Thursday, moving it a step closer to regulatory approval.
There were no cases of severe illness or deaths among those who got the vaccine, the company said, in a sign that it could stop the worse effects of new variants that have cropped up.
The vaccine was 86 er cent effective in protecting against the more contagious virus variant first discovered and now prevalent in the United Kingdom, for a combined 90% effectiveness rate overall based on data from infections of both versions of the coronavirus.
Novavax shares jumped 22% in after-hours trading to $229. They were trading below $10 on Jan. 21, 2020, when the company announced it was developing a coronavirus vaccine.
In a smaller trial conducted in South Africa - where volunteers were primarily exposed to another newer, more contagious variant widely circulating there and spreading around the world - the Novavax vaccine was 55% effective, based on people without HIV, but still fully prevented severe illness.
Novavax Chief Medical Officer Filip Dubovsky said the performance in South Africa suggests there may still be a case for using it in areas where the South African variant is dominant.
Novavax is also developing new formulations of its vaccine to protect against emerging variants and plans to initiate clinical testing of these shots in the second quarter of this year.
Results from the final analysis of the UK trial were largely in line with interim data released in January.
The company expects to use the data to submit for regulatory authorization in various countries. It is not clear when it will seek U.S. authorization or if regulators will require it to complete an ongoing trial in the United States.
Novavax expects data from a 30,000-person trial in the United States and Mexico by early April.
Dubovsky said that Novavax is still planning to file for authorization from UK regulators early in the second quarter of 2021.
The UK trial, which enrolled more than 15,000 people aged 18 to 84, assessed efficacy of the vaccine during a period with high transmission of the UK virus variant now circulating widely.
The shot’s effectiveness in the South Africa trial declined to around 49% when the analysis included data from HIV-positive participants.
The vaccine could be cleared for use in the United States as soon as May if U.S. regulators decide the UK data is enough to make a decision. It could take a couple months longer if they insist on first seeing data from the U.S. trial, its chief executive told Reuters earlier this month.
“Ultimately, they have to decide whether the data we can bring to the table is adequate or whether they would prefer to wait on data from our U.S. study,” Dubovsky said on Thursday.
Novavax plans to produce its two-shot vaccine at eight manufacturing locations, including the Serum Institute of India.
The paths of these two stars have intersected on several occasions due to their association with the luxury brand Bulgari
entertainment6 hours ago
The students' demands range from a ceasefire in Israel's war with Hamas to calls for universities to stop investing in Israeli enterprises
world6 hours ago
Despite Kohli's flowing form ahead of the T20 World Cup in June, pundits have raised concerns over his strike-rate
cricket6 hours ago
Saudi Arabia has begun to explore extracting lithium from sea water
business7 hours ago
Speaking after meeting Lebanese leaders, French foreign minister says there had been "a lot of progress" over the French proposals
mena7 hours ago
The three-shot winner from Japan says he is aiming to become a member of the PGA Tour in the future
sports7 hours ago
Big-hitting Nienaber falters at the finish to settle for secondwhile former Abu Dhabi resident David Horsey takes the third spot at Saadiyat Beach Golf Club
sports7 hours ago
The UAE is India's second-largest export destination after the US
economy8 hours ago